Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
Citation: Boominathan, Therapeutic insights into the treatment of Fibrosis: SMAD7 inhibits pulmonary fibrosis via up regulation of its target gene, 30/September/2014, 04.54 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Web: http://genomediscovery.org
Courtesy: When you cite drop us a line at info@genomediscovery.org
Significance: This study suggests that SMAD7, by increasing the expression of its target gene, it may decrease the expression of a number of extracellular matrix genes. Thereby, it may inhibit the progression of pulmonary fibrosis. Thus, this study suggests that pharmacological formulations encompassing “SMAD7 or its activators“ may be used to inhibit the progression of fibrotic diseases.
* Research cooperation